ISPC — iSpecimen Inc.

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1558569 ·
Last close
$0.60
Market Cap
$1.50M
52W High
$27.44
52W Low
$0.56
ADV30
226,191
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 151,940 68,650 -1,362,986 -1,362,811 7,393,201 4,414,364 5,656,821
Mar 2026 156,009 71,599 -2,538,403 -2,275,221 6,609,658 2,818,989 5,795,620
Dec 2025 51,761 -547,078 -2,687,882 -5,001,245 9,531,410 6,880,835 6,443,179
Sep 2025 106,592 -98,001 -2,830,222 -2,780,648 8,997,557 2,782,758 5,924,846

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,004,000
Investing CF
$-1,700,000
Financing CF
$10,243,489
CapEx
$-1,700,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-43.62
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-85,988,181
Inventory
$0
Receivables
$21,257
ST Investments
—
EBIT TTM
$-11,417,551
Pretax Income TTM
$-11,419,925
Interest Exp TTM
$2,374
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$466,302
EBITDA
$-9,284,936
Free Cash Flow
$-5,581,286
Enterprise Value
$-471,133
Total Cash
$4,414,364
Total Debt
$240,903
Shares Out
2,518,590
Trailing EPS
$-50.48
Book Value
$1.14
ROE
-968.5%
ROA
-87.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,928,998 -8,977,919 -10,487,532 9,531,410 6,443,179 3,088,231 -4,240,608
Dec 2024 9,291,115 -12,728,045 -12,497,805 9,350,230 6,039,222 3,311,008 -8,263,713
Dec 2023 9,928,184 -11,169,349 -11,099,488 15,819,137 6,078,060 9,741,077 -5,807,550
Dec 2022 10,402,303 -10,186,082 -10,245,922 24,617,653 4,308,483 20,309,170 -5,817,720

TTM Snapshot

Revenues TTM
$466,302
NetIncome TTM
$-11,419,925
OpCashFlow TTM
—
Assets (Latest)
$7,393,201
Forward EPS
$-0.79

Peers — same industry

TickerNameMarket CapLastDaily %
CBIH Cannabis Bioscience International Holdings, Inc. $1.74M $0.00 —
BIAF bioAffinity Technologies, Inc. $2.48M $1.93 —
QCLS Q/C TECHNOLOGIES, INC. $2.74M $0.33 —
BUDZ WEED, INC. $2.97M $0.02 —
NYMXF NYMOX PHARMACEUTICAL CORP $3.15M $0.03 —

News headlines (Yahoo Finance, 1h cache)

iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
2026-11-05 21:05 · Yahoo
iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent
2026-10-29 20:10 · Yahoo
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
2026-09-29 12:05 · Yahoo
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
2026-08-20 20:05 · Yahoo
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
2026-08-07 20:30 · Yahoo
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
2026-08-07 19:45 · Yahoo
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
2026-08-07 19:45 · Yahoo
iSpecimen Announces 1-for-40 Reverse Stock Split
2026-04-24 13:00 · Yahoo
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
2026-04-09 20:05 · Yahoo
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
2026-05-12 18:16 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.